Gynecologic Oncology | Michael Birrer, MD, PhD

Data + Perspectives: The Current and Future Role of Immune Checkpoint Inhibitors and Other Novel Therapies in the Management of Gynecologic Cancers — Faculty Presentation 2: Checkpoint Inhibitor Therapy for Microsatellite Instability-High and Microsatellite-Stable Endometrial Cancer — Dr Birrer CME information and select publications